| Year |
Citation |
Score |
| 2024 |
Abdelhakiem MK, Bao R, Pifer PM, Molkentine D, Molkentine J, Hefner A, Beadle B, Heymach JV, Luke JJ, Ferris RL, Pickering CR, Wang JH, Patel RB, Skinner HD. Th2 Cells Are Associated with Tumor Recurrence Following Radiation. Cancers. 16. PMID 38672668 DOI: 10.3390/cancers16081586 |
0.355 |
|
| 2024 |
Gleber-Netto FO, Nagarajan P, Sagiv O, Pickering CR, Gross N, Ning J, Yeshi MM, Mitku Y, Tetzlaff MT, Esmaeli B. Histologic and Genomic Analysis of Conjunctival SCC in African and American Cohorts Reveal UV Light and HPV Signatures and High Tumor Mutation Burden. Investigative Ophthalmology & Visual Science. 65: 24. PMID 38597722 DOI: 10.1167/iovs.65.4.24 |
0.303 |
|
| 2024 |
Zhao M, Wang T, Gleber-Netto FO, Chen Z, McGrail DJ, Gomez JA, Ju W, Gadhikar MA, Ma W, Shen L, Wang Q, Tang X, Pathak S, Raso MG, Burks JK, ... ... Pickering CR, et al. Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response. Nature Communications. 15: 180. PMID 38167338 DOI: 10.1038/s41467-023-44239-2 |
0.333 |
|
| 2023 |
Pifer PM, Yang L, Kumar M, Xie T, Frederick M, Hefner A, Beadle B, Molkentine D, Molkentine J, Dhawan A, Abdelhakiem M, Osman AA, Leibowitz BJ, Myers JN, Pickering CR, et al. FAK drives resistance to therapy in HPV-negative head and neck cancer in a p53-dependent manner. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37819945 DOI: 10.1158/1078-0432.CCR-23-0964 |
0.34 |
|
| 2023 |
Coleman N, Marcelo KL, Hopkins JF, Khan NI, Du R, Hong L, Park E, Balsara B, Leoni M, Pickering C, Myers J, Heymach J, Albacker LA, Hong D, Gillison M, et al. Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma. Jco Precision Oncology. 7: e2200211. PMID 36603172 DOI: 10.1200/PO.22.00211 |
0.329 |
|
| 2022 |
Chahoud J, Zacharias NM, Pham R, Qiao W, Guo M, Lu X, Alaniz A, Segarra L, Martinez-Ferrer M, Gleber-Netto FO, Pickering CR, Rao P, Pettaway CA. Prognostic Significance of p16 and Its Relationship with Human Papillomavirus Status in Patients with Penile Squamous Cell Carcinoma: Results of 5 Years Follow-Up. Cancers. 14. PMID 36551510 DOI: 10.3390/cancers14246024 |
0.333 |
|
| 2022 |
Callahan SC, Kochat V, Liu Z, Raman AT, Divenko M, Schulz J, Terranova CJ, Ghosh AK, Tang M, Johnson FM, Wang J, Skinner HD, Pickering CR, Myers JN, Rai K. High enhancer activity is an epigenetic feature of HPV negative atypical head and neck squamous cell carcinoma. Frontiers in Cell and Developmental Biology. 10: 936168. PMID 35927986 DOI: 10.3389/fcell.2022.936168 |
0.371 |
|
| 2022 |
Shi Y, Xie T, Wang B, Wang R, Cai Y, Yuan B, Gleber-Netto FO, Tian X, Rodriguez-Rosario AE, Osman AA, Wang J, Pickering CR, Ren X, Sikora AG, Myers JN, et al. Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma. Communications Biology. 5: 757. PMID 35902768 DOI: 10.1038/s42003-022-03675-4 |
0.343 |
|
| 2021 |
Molkentine DP, Molkentine JM, Bridges KA, Valdecanas DR, Dhawan A, Bahri R, Hefner AJ, Kumar M, Yang L, Abdelhakiem M, Pifer PM, Sandulache V, Sheth A, Beadle BM, Thames HD, ... ... Pickering CR, et al. p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade. Cancer Research. PMID 34965932 DOI: 10.1158/0008-5472.CAN-21-2101 |
0.326 |
|
| 2021 |
Gorur A, Patiño M, Shi T, Corrales G, Takahashi H, Rangel R, Gleber-Netto FO, Pickering C, Myers JN, Cata JP. Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor. Journal of Cellular Physiology. PMID 34038587 DOI: 10.1002/jcp.30421 |
0.322 |
|
| 2021 |
Chahoud J, Gleber-Netto FO, McCormick BZ, Rao P, Lu X, Guo M, Morgan MB, Chu RA, Martinez-Ferrer M, Eterovic AK, Pickering CR, Pettaway CA. Whole Exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognostic Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33441293 DOI: 10.1158/1078-0432.CCR-20-4004 |
0.338 |
|
| 2020 |
Campbell BR, Chen Z, Faden DL, Agrawal N, Li RJ, Hanna GJ, Iyer NG, Boot A, Rozen SG, Vettore AL, Panda B, Krishnan NM, Pickering CR, Myers JN, Guo X, et al. The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma. Cancer. PMID 33146897 DOI: 10.1002/cncr.33309 |
0.328 |
|
| 2020 |
Uzunparmak B, Gao M, Lindemann A, Erikson K, Wang L, Lin E, Frank SJ, Gleber-Netto FO, Zhao M, Skinner HD, Newton JM, Sikora AG, Myers JN, Pickering CR. Caspase 8 loss radiosensitizes head and neck squamous cell carcinoma to SMAC mimetic induced necroptosis. Jci Insight. PMID 33108350 DOI: 10.1172/jci.insight.139837 |
0.393 |
|
| 2020 |
Gleber-Netto FO, Neskey D, Costa AFM, Kataria P, Rao X, Wang J, Kowalski LP, Pickering CR, Dias-Neto E, Myers JN. Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma. Cancer. PMID 32797678 DOI: 10.1002/Cncr.33101 |
0.454 |
|
| 2020 |
Facompre ND, Rajagopalan P, Sahu V, Pearson AT, Montone KT, James CD, Gleber-Netto FO, Weinstein GS, Jalaly J, Lin A, Rustgi AK, Nakagawa H, Califano JA, Pickering CR, White EA, et al. Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models. International Journal of Cancer. PMID 32478869 DOI: 10.1002/Ijc.33125 |
0.458 |
|
| 2020 |
Molkentine JM, Molkentine DP, Bridges KA, Xie T, Yang L, Sheth A, Heffernan TP, Clump DA, Faust AZ, Ferris R, Myers JN, Frederick MJ, Mason KA, Meyn RE, Pickering CR, et al. Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints. International Journal of Radiation Biology. 1-14. PMID 32073931 DOI: 10.1080/09553002.2020.1730014 |
0.307 |
|
| 2020 |
Chahoud J, Pham R, Guo M, Pickering CR, Qiao W, Khanna A, Netto F, Pettaway CA, Rao P. p16INK4a expression and survival outcomes in patients with penile squamous cell carcinoma: The M.D. Anderson Cancer Center Experience. Journal of Clinical Oncology. 38: 5-5. DOI: 10.1200/Jco.2020.38.6_Suppl.5 |
0.428 |
|
| 2020 |
Chahoud J, Netto F, Lazcano Segura R, Parra Cuentas ER, Lu X, Rao P, Wistuba II, Pickering CR, Pettaway CA. Tumor immune microenvironment alterations in penile squamous cell carcinoma using multiplex immunofluorescence and image analysis approaches. Journal of Clinical Oncology. 38: 4-4. DOI: 10.1200/Jco.2020.38.6_Suppl.4 |
0.417 |
|
| 2020 |
Abdelhakiem M, Bao R, Ferris RL, Pickering CR, Skinner HD. Association of radiation treatment failure in head and neck cancer with differential immune infiltrate. Journal of Clinical Oncology. 38: 6558-6558. DOI: 10.1200/Jco.2020.38.15_Suppl.6558 |
0.397 |
|
| 2020 |
Gleber-Netto FO, Gao M, Shen L, Wang J, Myers JN, Johnson FM, Pickering CR. Abstract B14: Variations in the proteasome activity are associated with human papilloma virus (HPV) gene expression and patient survival in HPV+ oropharyngeal tumors Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Aacrahns19-B14 |
0.424 |
|
| 2020 |
Facompre ND, Rajagopalan P, Pearson AT, Montone KT, James CD, Gleber-Netto FO, Nakagawa H, White EA, Rustgi AK, Califano JA, Pickering CR, Windle B, Morgan IM, Gimotty PA, Basu D. Abstract A01: HPV+ oral cancer PDXs identify prognostic utility for E2F target gene expression and mutation burden Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Aacrahns19-A01 |
0.451 |
|
| 2020 |
Facompre ND, Rajagopalan P, Sahu V, Gleber-Netto FO, Califano JA, Pickering CR, Gimotty PA, Basu D. Abstract A03: Predictors of HPV-related head and neck cancer progression identified through patient-derived models Cancer Research. 80. DOI: 10.1158/1538-7445.Camodels2020-A03 |
0.423 |
|
| 2020 |
Abdelhakiem MK, Yang L, Xie T, Kumar M, Molkentine D, Sheth A, Frederick M, Myers J, Pickering CR, Skinner HD. Abstract 6185: In vivo screening in HPV positive and HPV negative head and neck squamous cell carcinoma Cancer Research. 80: 6185-6185. DOI: 10.1158/1538-7445.Am2020-6185 |
0.438 |
|
| 2020 |
Jad Chahoud M, Netto F, Lazcano Segura R, Parrra Cuentes ER, Lu X, Priya Rao M, Wistuba II, Pickering CR, Pettaway* C. PD19-11 TUMOR IMMUNE MICROENVIRONMENT ALTERATIONS IN PENILE SQUAMOUS CELL CARCINOMA USING MULTIPLEX IMMUNOFLUORESCENCE AND IMAGE ANALYSIS APPROACHES The Journal of Urology. 203: e386. DOI: 10.1097/Ju.0000000000000862.011 |
0.357 |
|
| 2020 |
Chahoud J, Pham* R, Guo M, Pickering C, Qiao W, Khanna A, Netto F, Pettaway C, Yao P. MP11-16 P16INK4A EXPRESSION AND SURVIVAL OUTCOMES IN PATIENTS WITH PENILE SQUAMOUS CELL CARCINOMA The Journal of Urology. 203: e141-e142. DOI: 10.1097/Ju.0000000000000831.016 |
0.468 |
|
| 2019 |
Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Xie TX, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma. Oral Oncology. 97: 56-61. PMID 31421472 DOI: 10.1016/J.Oraloncology.2019.07.028 |
0.36 |
|
| 2019 |
Chari NS, Ivan C, Le X, Li J, Mijiti A, Patel AA, Osman AA, Peterson CB, Williams MD, Pickering CR, Caulin C, Myers JN, Calin GA, Lai SY. Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer. Journal of the National Cancer Institute. PMID 31124563 DOI: 10.1093/Jnci/Djz097 |
0.313 |
|
| 2019 |
Chahoud J, Pickering CR, Pettaway CA. Genetics and penile cancer: recent developments and implications. Current Opinion in Urology. PMID 31045928 DOI: 10.1097/Mou.0000000000000640 |
0.385 |
|
| 2019 |
Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Xie TX, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. Identification of novel diagnostic markers for sinonasal undifferentiated carcinoma. Head & Neck. PMID 30932264 DOI: 10.1002/Hed.25748 |
0.42 |
|
| 2019 |
Sambandam V, Frederick MJ, Shen L, Tong P, Rao X, Peng S, Singh R, Mazumdar T, Huang C, Li Q, Pickering CR, Myers JN, Wang J, Johnson FM. PDK1 mediates NOTCH1-mutated head and neck squamous carcinoma vulnerability to therapeutic PI3K/mTOR inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30770351 DOI: 10.1158/1078-0432.Ccr-18-3276 |
0.468 |
|
| 2019 |
Gleber-Netto FO, Rao X, Guo T, Xi Y, Gao M, Shen L, Erikson K, Kalu NN, Ren S, Xu G, Fisch KM, Akagi K, Seiwert T, Gillison M, Frederick MJ, ... ... Pickering CR, et al. Variations in HPV function are associated with survival in squamous cell carcinoma. Jci Insight. 4. PMID 30626753 DOI: 10.1172/Jci.Insight.124762 |
0.406 |
|
| 2019 |
Chahoud J, McCormick BZ, Netto F, Rao P, Pickering CR, Pettaway CA. Penile squamous cell carcinoma is genomically similar to other HPV-driven tumors. Journal of Clinical Oncology. 37: 505-505. DOI: 10.1200/Jco.2019.37.7_Suppl.505 |
0.472 |
|
| 2019 |
Le X, Pickering CR, Rubin ML, Netto F, Kies MS, Johnson FM, Lu C, Blumenschein GR, Bell D, Ginsberg LE, Wilson KF, Lewis J, Feng L, Wang J, Lee JJ, et al. Induction chemotherapy with and without erlotinib in patients with oral cavity squamous cell carcinomas (OCSCCs) amenable for surgical resection. Journal of Clinical Oncology. 37: 6067-6067. DOI: 10.1200/Jco.2019.37.15_Suppl.6067 |
0.305 |
|
| 2019 |
Basu D, Facompre ND, Gimotty PA, Rajagopalan P, Sahu V, Pearson AT, Califano JA, Netto F, Pickering CR. Identifying adverse molecular features of HPV+ head and neck cancers using patient-derived models. Journal of Clinical Oncology. 37: 6057-6057. DOI: 10.1200/Jco.2019.37.15_Suppl.6057 |
0.42 |
|
| 2019 |
Michikawa C, Torres-Saavedra PA, Silver NL, Harari PM, Kies MS, Rosenthal DI, Le Q, Jordan RC, Duose DY, Mallampati S, Trivedi S, Luthra R, Wistuba II, Lichtarge O, Foote RL, ... ... Pickering CR, et al. Evolutionary action score of TP53 analysis in pathologically high-risk HPV-negative head and neck cancer from a phase II clinical trial: NRG Oncology RTOG 0234. Journal of Clinical Oncology. 37: 6010-6010. DOI: 10.1200/Jco.2019.37.15_Suppl.6010 |
0.403 |
|
| 2019 |
Molkentine D, Bridges K, Sheth A, Valdecanas D, Pickering C, Skinner HD. Abstract 2919: p16 modulates a novel ubiquitin signaling cascade which regulates radioresponse and offers clinically relevant therapeutic targets in squamous cell carcinoma Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2919 |
0.434 |
|
| 2019 |
Zhao M, Wang T, Zhen C, Wang J, Pickering CR, Chen J, Myers JN, Zhou G. Abstract 5289: Gain-of-function mutant p53 predisposes head and neck keratinocytes and squamous cell carcinoma cells to replicative stress and genomic instability through minichromosome maintenance complex component 5 Cancer Research. 79: 5289-5289. DOI: 10.1158/1538-7445.Am2019-5289 |
0.477 |
|
| 2019 |
Gleber-Netto FO, Gao M, Rao X, Vellano CP, Marszalek JR, Wang J, Johnson FM, Pickering CR. Abstract 4942: Variations in HPV function are associated with patient outcome and identify new candidate therapeutic approaches Cancer Research. 79: 4942-4942. DOI: 10.1158/1538-7445.Am2019-4942 |
0.418 |
|
| 2019 |
Sambandam V, Shen L, Peng S, Mazumdar T, Pickering C, Myers J, Wang J, Frederick M, Johnson F. Abstract 3913: PDK1 drives susceptibility ofNOTCH1mutant head and neck squamous carcinoma to PI3K/mTOR pathway inhibition Cancer Research. 79: 3913-3913. DOI: 10.1158/1538-7445.Am2019-3913 |
0.469 |
|
| 2019 |
McCormick* B, Chahoud J, Netto F, Rao P, Pickering C, Pettaway C. MP73-11 PENILE SQUAMOUS CELL CARCINOMA IS GENOMICALLY SIMILAR TO OTHER HPV-DRIVEN TUMORS Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557257.46397.22 |
0.45 |
|
| 2019 |
Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. PFKFB2 as a Potential Survival Marker in Sinonasal Undifferentiated Carcinoma Skull Base Surgery. 80. DOI: 10.1055/S-0039-1679430 |
0.344 |
|
| 2018 |
Haddad RI, Massarelli E, Lee JJ, Lin HY, Hutcheson K, Lewis J, Garden AS, Blumenschein GR, William WN, Pharaon RR, Tishler RB, Glisson BS, Pickering C, Gold KA, Johnson FM, et al. Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 30596812 DOI: 10.1093/Annonc/Mdy549 |
0.377 |
|
| 2018 |
Clump DA, Pickering CR, Skinner HD. Predicting Outcome in Head and Neck Cancer: miRNAs with potentially big effects. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30413524 DOI: 10.1158/1078-0432.Ccr-18-3078 |
0.391 |
|
| 2018 |
Choi BK, Dayaram T, Parikh N, Wilkins AD, Nagarajan M, Novikov IB, Bachman BJ, Jung SY, Haas PJ, Labrie JL, Pickering CR, Adikesavan AK, Regenbogen S, Kato L, Lelescu A, et al. Literature-based automated discovery of tumor suppressor p53 phosphorylation and inhibition by NEK2. Proceedings of the National Academy of Sciences of the United States of America. PMID 30266789 DOI: 10.1073/Pnas.1806643115 |
0.348 |
|
| 2018 |
Ma J, Fu Y, Tu YY, Liu Y, Tan YR, Ju WT, Pickering CR, Myers JN, Zhang ZY, Zhong LP. Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma. Bmc Cancer. 18: 758. PMID 30041611 DOI: 10.1186/S12885-018-4481-8 |
0.418 |
|
| 2018 |
Kalu NN, Mazumdar T, Peng S, Tong P, Shen L, Wang J, Banerjee U, Myers JN, Pickering CR, Brunell D, Stephan CC, Johnson FM. Comprehensive pharmacogenomic profiling of human papillomavirus-positive and -negative squamous cell carcinoma identifies sensitivity to aurora kinase inhibition in KMT2D mutants. Cancer Letters. PMID 29807113 DOI: 10.1016/J.Canlet.2018.05.029 |
0.468 |
|
| 2018 |
Campbell JD, Yau C, Bowlby R, Liu Y, Brennan K, Fan H, Taylor AM, Wang C, Walter V, Akbani R, Byers LA, Creighton CJ, Coarfa C, Shih J, Cherniack AD, ... ... Pickering CR, et al. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas. Cell Reports. 23: 194-212.e6. PMID 29617660 DOI: 10.1016/J.Celrep.2018.03.063 |
0.469 |
|
| 2018 |
Abram TJ, Pickering CR, Lang AK, Bass NE, Raja R, Meena C, Alousi AM, Myers JN, McDevitt JT, Gillenwater AM, Vigneswaran N. Risk Stratification of Oral Potentially Malignant Disorders in Fanconi Anemia Patients Using Autofluorescence Imaging and Cytology-On-A Chip Assay. Translational Oncology. 11: 477-486. PMID 29481998 DOI: 10.1016/J.Tranon.2018.01.014 |
0.383 |
|
| 2018 |
Radovich M, Pickering CR, Felau I, Ha G, Zhang H, Jo H, Hoadley KA, Anur P, Zhang J, McLellan M, Bowlby R, Matthew T, Danilova L, Hegde AM, Kim J, et al. The Integrated Genomic Landscape of Thymic Epithelial Tumors. Cancer Cell. 33: 244-258.e10. PMID 29438696 DOI: 10.1016/J.Ccell.2018.01.003 |
0.389 |
|
| 2018 |
Sandulache VC, Michikawa C, Kataria P, Gleber-Netto FO, Bell D, Trivedi S, Rao X, Wang J, Zhao M, Jasser SA, Myers JN, Pickering CR. High-risk TP53 mutations are associated with extra nodal extension (ENE) in oral cavity squamous cell carcinoma (OSCC). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29330202 DOI: 10.1158/1078-0432.Ccr-17-0721 |
0.446 |
|
| 2018 |
Kumar M, Bridges K, Molkentine D, Yang L, Sheth A, Meyn R, Frederick M, Myers J, Pickering C, Skinner HD. Abstract 978: In vivo shRNA screening identifies synthetic cytotoxicity in CREBBP/EP300 mutant head and neck cancer Cancer Research. 78: 978-978. DOI: 10.1158/1538-7445.Am2018-978 |
0.506 |
|
| 2018 |
Mazumdar T, Kalu NN, Peng S, Tong P, Shen L, Wang J, Myers JN, Pickering CR, Brunell D, Stephan CC, Johnson FM. Abstract 4646: Pharmacogenomic screen identifies KMT2D mutations as a biomarker of sensitivity to Aurora kinase inhibition in head and neck and cervical squamous cell carcinoma Cancer Research. 78: 4646-4646. DOI: 10.1158/1538-7445.Am2018-4646 |
0.47 |
|
| 2018 |
Sambandam V, Shen L, Tong P, Peng S, Mazumdar T, Singh R, Pickering CR, Myers JN, Wang J, Frederick M, Johnson FM. Abstract 2977: PI3K/mTOR pathway inhibition induces Aurora B mediated cell death in NOTCH1 mutant head and neck squamous (HNSCC) cells Cancer Research. 78: 2977-2977. DOI: 10.1158/1538-7445.Am2018-2977 |
0.421 |
|
| 2018 |
Colbert L, Kumar M, Yang L, Molkentine D, Bridges K, Myers J, Xie T, Frederick M, Pickering C, Skinner H. In Vivo shRNA Screening Reveals Differential Radiosensitization Within HPV+ and HPV- Head and Neck Squamous Cell Carcinomas International Journal of Radiation Oncology*Biology*Physics. 102: S119. DOI: 10.1016/J.Ijrobp.2018.06.297 |
0.404 |
|
| 2017 |
Gadhikar MA, Zhang J, Shen L, Rao X, Wang J, Zhao M, Kalu NN, Johnson FM, Byers LA, Heymach J, Hittelman WN, Udayakumar D, Pandita RK, Pandita TK, Pickering CR, et al. CDKN2A/p16 deletion in head and neck cancer cells is associated with Cdk2 activation, replication stress, and vulnerability to Chk1 inhibition. Cancer Research. PMID 29229598 DOI: 10.1158/0008-5472.Can-17-2802 |
0.46 |
|
| 2017 |
Kalu NN, Mazumdar T, Peng S, Shen L, Sambandam V, Rao X, Xi Y, Li L, Qi Y, Gleber-Netto FO, Patel A, Wang J, Frederick MJ, Myers JN, Pickering CR, et al. Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines. Oncotarget. 8: 86369-86383. PMID 29156801 DOI: 10.18632/Oncotarget.21174 |
0.436 |
|
| 2017 |
Gleber-Netto FO, Zhao M, Trivedi S, Wang J, Jasser S, McDowell C, Kadara H, Zhang J, Wang J, William WN, Lee JJ, Nguyen ML, Pai SI, Walline HM, Shin DM, ... ... Pickering CR, et al. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma. Cancer. PMID 29053175 DOI: 10.1002/Cncr.31063 |
0.336 |
|
| 2017 |
Chen TW, Lee CC, Liu H, Wu CS, Pickering CR, Huang PJ, Wang J, Chang IY, Yeh YM, Chen CD, Li HP, Luo JD, Tan BC, Chan TEH, Hsueh C, et al. APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism. Nature Communications. 8: 465. PMID 28878238 DOI: 10.1038/S41467-017-00493-9 |
0.471 |
|
| 2017 |
Tanaka N, Patel AA, Tang L, Silver NL, Lindemann A, Takahashi H, Jaksik R, Rao X, Kalu NN, Chen TC, Wang J, Frederick MJ, Johnson FM, Gleber-Netto F, Fu S, ... ... Pickering CR, et al. Replication stress leading to apoptosis within the S-phase contributes to synergism between vorinostat and AZD1775 in HNSCC harboring high risk TP53 mutation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28790110 DOI: 10.1158/1078-0432.Ccr-17-0947 |
0.496 |
|
| 2017 |
Morris VK, Rao X, Pickering CR, Foo WC, Rashid A, Eterovic AK, Kim TB, Chen K, Wang J, Shaw K, Eng C. Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal. Molecular Cancer Research : McR. PMID 28784613 DOI: 10.1158/1541-7786.Mcr-17-0060 |
0.477 |
|
| 2017 |
Skinner HD, Giri U, Yang LP, Kumar M, Liu Y, Story MD, Pickering CR, Byers LA, Williams MD, Wang J, Shen L, Yoo SY, Fan YH, Molkentine DP, Beadle BM, et al. Integrative Analysis Identifies a Novel AXL-PI3 Kinase-PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28476872 DOI: 10.1158/1078-0432.Ccr-16-2586 |
0.388 |
|
| 2017 |
Chang KP, Wang CI, Pickering CR, Huang Y, Tsai CN, Tsang NM, Kao HK, Cheng MH, Myers JN. Prevalence of promoter mutations in the TERT gene in oral cavity squamous cell carcinoma. Head & Neck. PMID 28230921 DOI: 10.1002/Hed.24728 |
0.428 |
|
| 2017 |
Zhang M, Singh R, Peng S, Mazumdar T, Sambandam V, Shen L, Tong P, Li L, Kalu N, Pickering CR, Frederick M, Myers JN, Wang J, Johnson FM. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors. Cancer Letters. PMID 28126323 DOI: 10.1016/J.Canlet.2017.01.024 |
0.474 |
|
| 2017 |
Xie T, Parimi RL, Kumar MF, Yang LP, Wang J, Seth S, Alessandro C, Bristow CA, Robinson FS, Peoples MD, Skinner H, Myers JN, Pickering CR, Frederick MJ. Abstract IA12: An in vivo high throughput shRNA screening platform for identifying ways to target genomic alterations Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Aacrahns17-Ia12 |
0.449 |
|
| 2017 |
Chang K, Chen T, Pickering CR, Myers JN, Chang Y. Abstract IA10: Integrated omics analyses identify prognostic biomarkers of oral cavity squamous cell carcinoma in Taiwan Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Aacrahns17-Ia10 |
0.481 |
|
| 2017 |
Takahashi Y, Bell D, Gleber-Netto FO, Xie T, Roberts D, Pickering C, Myers JN, Hanna EY. Abstract 42: Identification of gene expression patterns distinguishing responders and non-responders to induction chemotherapy in sinonasal undifferentiated carcinoma Clinical Cancer Research. 23: 42-42. DOI: 10.1158/1557-3265.Aacrahns17-42 |
0.401 |
|
| 2017 |
Uzunparmak B, Lindemann A, Frederick MJ, Myers JN, Pickering CR. Abstract 04: Caspase-8 is a novel candidate driver gene in head and neck squamous cell carcinoma Clinical Cancer Research. 23: 4-4. DOI: 10.1158/1557-3265.Aacrahns17-04 |
0.508 |
|
| 2017 |
Pickering CR, Xie T, Kumar M, Parimi RL, Yang LP, Wang J, Seth S, Bristow CA, Carugo A, Robinson FS, Draetta GF, Skinner H, Frederick MJ, Myers JN. Abstract 415:In vivoshRNA library screening to identify novel targets for head and neck squamous cell carcinoma Cancer Research. 77: 415-415. DOI: 10.1158/1538-7445.Am2017-415 |
0.407 |
|
| 2017 |
Zhang M, Ratnakar S, Peng S, Tuhina M, Li S, Tong P, Pickering C, Myers JN, Wang J, Johnson FM. Abstract 3816: Mutations of the lim protein ajuba mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell cycle inhibitors Cancer Research. 77: 3816-3816. DOI: 10.1158/1538-7445.Am2017-3816 |
0.453 |
|
| 2017 |
Sambandam V, Shen L, Tong P, Mazumdar T, Pickering C, Myers JN, Wang J, Frederick M, Johnson FM. Abstract 2992: Identification ofNOTCH1inactivating mutation as a therapeutic vulnerability to PI3K/mTOR pathway inhibition in head and neck squamous cell carcinoma (HNSCC) Cancer Research. 77: 2992-2992. DOI: 10.1158/1538-7445.Am2017-2992 |
0.481 |
|
| 2017 |
Takahashi Y, Bell D, Netto F, Xie T, Roberts D, Pickering C, Myers J, Hanna E. Gene Expression Signature in Sinonasal Undifferentiated Carcinoma Journal of Neurological Surgery Part B: Skull Base. 78: S1-S156. DOI: 10.1055/S-0037-1600612 |
0.362 |
|
| 2016 |
Chitsazzadeh V, Coarfa C, Drummond JA, Nguyen T, Joseph A, Chilukuri S, Charpiot E, Adelmann CH, Ching G, Nguyen TN, Nicholas C, Thomas VD, Migden M, MacFarlane D, Thompson E, ... ... Pickering C, et al. Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates. Nature Communications. 7: 12601. PMID 27574101 DOI: 10.1038/Ncomms12601 |
0.378 |
|
| 2016 |
Skinner HD, Giri U, Yang L, Woo SH, Story MD, Pickering CR, Byers LA, Williams MD, El-Naggar A, Wang J, Diao L, Shen L, Fan YH, Molkentine DP, Beadle BM, et al. Proteomic profiling identifies PTK2/FAK as a driver of radioresistance in HPV negative head and neck cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27036135 DOI: 10.1158/1078-0432.Ccr-15-2785 |
0.434 |
|
| 2016 |
Takahashi Y, Lee J, Pickering C, Bell D, Jiffar TW, Myers JN, Hanna EY, Kupferman ME. Human epidermal growth factor receptor 2/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma. Head & Neck. PMID 26752332 DOI: 10.1002/Hed.24350 |
0.402 |
|
| 2016 |
Skinner HD, Giri U, Story MD, Wang J, Shen L, Yoo SY, Byers LA, Pickering CR, Myers J, Williams MD, Heymach J. Proteomic and mRNA expression analysis identifies PDL-1 expression as a marker of treatment failure in head and neck cancer. Journal of Clinical Oncology. 34: 6042-6042. DOI: 10.1200/Jco.2016.34.15_Suppl.6042 |
0.398 |
|
| 2016 |
Zhang M, Peng S, Mazumdar T, Sambandam V, Shen L, Tong P, Li L, Byers L, Pickering C, Frederick M, Myers JN, Wang J, Johnson FM. Abstract 4757: Identification of biomarkers that predict response of head and neck squamous cell carcinoma to mitotic inhibitors Cancer Research. 76: 4757-4757. DOI: 10.1158/1538-7445.Am2016-4757 |
0.477 |
|
| 2016 |
Johnson FM, Sambandam V, Shen L, Zhang M, Saigal R, Tong P, Mazumdar T, Byers LA, Pickering C, Myers JN, Wang J, Frederick M. Abstract 393: NOTCH1 inactivating mutation mediates sensitivity to PI3K/mTOR inhibitors in head and neck squamous cell carcinoma Cancer Research. 76: 393-393. DOI: 10.1158/1538-7445.Am2016-393 |
0.5 |
|
| 2015 |
Foy JP, Pickering CR, Papadimitrakopoulou VA, Jelinek J, Lin SH, William WN, Mitchell FT, Wang J, Lang W, Feng L, Zhang L, Kim ES, Fan YH, Hong WK, El-Naggar A, et al. New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development. Cancer Prevention Research (Philadelphia, Pa.). PMID 26342026 DOI: 10.1158/1940-6207.Capr-14-0179 |
0.347 |
|
| 2015 |
Wang Y, Springer S, Mulvey CL, Silliman N, Schaefer J, Sausen M, James N, Rettig EM, Guo T, Pickering CR, Bishop JA, Chung CH, Califano JA, Eisele DW, Fakhry C, et al. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas. Science Translational Medicine. 7: 293ra104. PMID 26109104 DOI: 10.1126/Scitranslmed.Aaa8507 |
0.385 |
|
| 2015 |
Woo SH, Yang LP, Chuang HC, Fitzgerald A, Lee HY, Pickering C, Myers JN, Skinner HD. Down-regulation of malic enzyme 1 and 2: Sensitizing head and neck squamous cell carcinoma cells to therapy-induced senescence. Head & Neck. PMID 25994759 DOI: 10.1002/Hed.24129 |
0.428 |
|
| 2015 |
Osman AA, Neskey DM, Katsonis P, Patel AA, Ward AM, Hsu TK, Hicks SC, McDonald TO, Ow TJ, Alves MO, Pickering CR, Skinner HD, Zhao M, Sturgis EM, Kies MS, et al. Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients. Cancer Research. 75: 1205-15. PMID 25691460 DOI: 10.1158/0008-5472.Can-14-2729 |
0.407 |
|
| 2015 |
Neskey DM, Osman AA, Ow TJ, Katsonis P, McDonald T, Hicks SC, Hsu TK, Pickering CR, Ward A, Patel A, Yordy JS, Skinner HD, Giri U, Sano D, Story MD, et al. Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer. Cancer Research. 75: 1527-36. PMID 25634208 DOI: 10.1158/0008-5472.Can-14-2735 |
0.434 |
|
| 2015 |
Sambandam V, Shen L, Zhang M, Saigal R, Byers LA, Pickering C, Myers JN, Wang J, Johnson FM. Abstract 417: Integrative drug sensitivity analysis of PI3K /mTOR pathway inhibitors in Head and Neck Squamous Cell Carcinoma (HNSCC) Cancer Research. 75: 417-417. DOI: 10.1158/1538-7445.Am2015-417 |
0.398 |
|
| 2015 |
Moorthy S, Saade R, Pickering C, Neskey D, Tanaka N, Zweidler-McKay P, Frederick M, Myers J. Abstract 3934: Restoration of NOTCH signaling in head and neck squamous cell carcinoma inhibits tumor growth and cell migratory abilities Cancer Research. 75: 3934-3934. DOI: 10.1158/1538-7445.Am2015-3934 |
0.488 |
|
| 2015 |
Skinner HD, Giri U, Yordy JS, Story MD, Wang J, Byers LA, Williams MD, El-Naggar AK, Woo SH, Yang LP, Fan Y, Pickering CR, Myers JN, Heymach JV. Abstract 3441: Proteomic profiling identifies PTK2/FAK as a targetable marker of radioresistance in head and neck cancer Cancer Research. 75: 3441-3441. DOI: 10.1158/1538-7445.Am2015-3441 |
0.493 |
|
| 2014 |
Pickering CR, Zhou JH, Lee JJ, Drummond JA, Peng SA, Saade RE, Tsai KY, Curry JL, Tetzlaff MT, Lai SY, Yu J, Muzny DM, Doddapaneni H, Shinbrot E, Covington KR, et al. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6582-92. PMID 25303977 DOI: 10.1158/1078-0432.Ccr-14-1768 |
0.425 |
|
| 2014 |
Pickering CR, Zhang J, Neskey DM, Zhao M, Jasser SA, Wang J, Ward A, Tsai CJ, Ortega Alves MV, Zhou JH, Drummond J, El-Naggar AK, Gibbs R, Weinstein JN, Wheeler DA, et al. Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3842-8. PMID 24874835 DOI: 10.1158/1078-0432.Ccr-14-0565 |
0.439 |
|
| 2014 |
Guerrero-Preston R, Michailidi C, Marchionni L, Pickering CR, Frederick MJ, Myers JN, Yegnasubramanian S, Hadar T, Noordhuis MG, Zizkova V, Fertig E, Agrawal N, Westra W, Koch W, Califano J, et al. Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer. Epigenetics : Official Journal of the Dna Methylation Society. 9: 1031-46. PMID 24786473 DOI: 10.4161/Epi.29025 |
0.423 |
|
| 2014 |
Bailey AM, Zhan L, Maru D, Shureiqi I, Pickering CR, Kiriakova G, Izzo J, He N, Wei C, Baladandayuthapani V, Liang H, Kopetz S, Powis G, Guo GL. FXR silencing in human colon cancer by DNA methylation and KRAS signaling. American Journal of Physiology. Gastrointestinal and Liver Physiology. 306: G48-58. PMID 24177031 DOI: 10.1152/Ajpgi.00234.2013 |
0.366 |
|
| 2014 |
Hah JH, Zhao M, Pickering CR, Frederick MJ, Andrews GA, Jasser SA, Fooshee DR, Milas ZL, Galer C, Sano D, William WN, Kim E, Heymach J, Byers LA, Papadimitrakopoulou V, et al. HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells. Head & Neck. 36: 1547-54. PMID 24123531 DOI: 10.1002/Hed.23499 |
0.405 |
|
| 2014 |
Guerrero-Preston R, Michailidi C, Marchionni L, Pickering C, Frederick M, Myers J, Yegnasubramanian S, Hadar T, Noordhuis M, Fertig E, Agrawal N, Westra W, Koch W, Califano J, Velculescu V, et al. Abstract 2482: Key tumor suppressor genes inactivated by promoter methylation and somatic mutations in head and neck cancer Cancer Research. 74: 2482-2482. DOI: 10.1158/1538-7445.Am2014-2482 |
0.431 |
|
| 2014 |
Takahashi Y, Pickering C, Gelbard A, Drummond J, Wheeler D, Kupferman M, Myers J, Hanna E. Genomic Characterization of Sinonasal Undifferentiated Carcinoma Journal of Neurological Surgery Part B: Skull Base. 75. DOI: 10.1055/S-0034-1370490 |
0.338 |
|
| 2013 |
Gadhikar MA, Sciuto MR, Alves MV, Pickering CR, Osman AA, Neskey DM, Zhao M, Fitzgerald AL, Myers JN, Frederick MJ. Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53. Molecular Cancer Therapeutics. 12: 1860-73. PMID 23839309 DOI: 10.1158/1535-7163.Mct-13-0157 |
0.501 |
|
| 2013 |
Pickering CR, Shah K, Ahmed S, Rao A, Frederick MJ, Zhang J, Unruh AK, Wang J, Ginsberg LE, Kumar AJ, Myers JN, Hamilton JD. CT imaging correlates of genomic expression for oral cavity squamous cell carcinoma. Ajnr. American Journal of Neuroradiology. 34: 1818-22. PMID 23764725 DOI: 10.3174/Ajnr.A3635 |
0.392 |
|
| 2013 |
Mroz EA, Tward AD, Pickering CR, Myers JN, Ferris RL, Rocco JW. High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma. Cancer. 119: 3034-42. PMID 23696076 DOI: 10.1002/Cncr.28150 |
0.41 |
|
| 2013 |
Pickering CR, Zhang J, Yoo SY, Bengtsson L, Moorthy S, Neskey DM, Zhao M, Ortega Alves MV, Chang K, Drummond J, Cortez E, Xie TX, Zhang D, Chung W, Issa JP, et al. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discovery. 3: 770-81. PMID 23619168 DOI: 10.1158/2159-8290.Cd-12-0537 |
0.476 |
|
| 2013 |
Pickering CR, Myers JN. Bcl-2 inhibition or FBXW7 mutation sensitizes solid tumor cells to HDAC inhibition in vitro but could prove difficult to validate in patients. Cancer Discovery. 3: 258-9. PMID 23475877 DOI: 10.1158/2159-8290.Cd-13-0019 |
0.36 |
|
| 2013 |
Loyo M, Li RJ, Bettegowda C, Pickering CR, Frederick MJ, Myers JN, Agrawal N. Lessons learned from next-generation sequencing in head and neck cancer. Head & Neck. 35: 454-63. PMID 22907887 DOI: 10.1002/Hed.23100 |
0.409 |
|
| 2013 |
Gadhikar MA, Sciuto MR, Ortega MVA, Pickering C, Monroe M, Osman A, Neskey D, Sturgis EM, Myers JN, Frederick MJ. Abstract 708: Overcoming the cisplatin resistance of HNSCC cells through Chk1/2 inhibition. Cancer Research. 73: 708-708. DOI: 10.1158/1538-7445.Am2013-708 |
0.49 |
|
| 2013 |
Fried D, Pickering C, Rao A, Hunter L, Shah K, Ahmed S, Frederick M, Zhang J, Unruh A, Wang J, Ginsberg L, Kumar A, Myers J, Court L, Hamilton J. SU-E-CAMPUS-I-06: Imaging Biomarkers of CT Textural Analysis Correlate to Genomic Expression in Oral Cavity Squamous Cell Carcinoma Medical Physics. 40: 377-378. DOI: 10.1118/1.4815172 |
0.359 |
|
| 2012 |
Sandulache VC, Skinner HD, Ow TJ, Zhang A, Xia X, Luchak JM, Wong LJ, Pickering CR, Zhou G, Myers JN. Individualizing antimetabolic treatment strategies for head and neck squamous cell carcinoma based on TP53 mutational status. Cancer. 118: 711-21. PMID 21720999 DOI: 10.1002/Cncr.26321 |
0.492 |
|
| 2012 |
Saintigny P, Lang W, Jelinek J, Pickering CR, Feng L, Frederick MJ, Zhang L, Ren H, Lee JJ, Kim ES, Fan YH, El-Naggar AK, Hong WK, Myers J, Papadimitrakopoulou V, et al. New DNA methylation markers associated with oral cancer (OC) development (dvlpt). Journal of Clinical Oncology. 30: 5524-5524. DOI: 10.1200/Jco.2012.30.15_Suppl.5524 |
0.342 |
|
| 2011 |
Saintigny P, Jelinek J, Pickering CR, Lang W, Frederick MJ, Zhang L, Ren H, Papadimitrakopoulou V, Lee JJ, Kim ES, Fan YH, El-Naggar AK, Hong WK, Myers J, Issa JJ, et al. DNA methyltransferase-3B (DNMT3B) in oral cancer (OC) development. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1506. PMID 28023622 DOI: 10.1200/Jco.2011.29.15_Suppl.1506 |
0.308 |
|
| 2011 |
Sano D, Xie TX, Ow TJ, Zhao M, Pickering CR, Zhou G, Sandulache VC, Wheeler DA, Gibbs RA, Caulin C, Myers JN. Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6658-70. PMID 21903770 DOI: 10.1158/1078-0432.Ccr-11-0046 |
0.471 |
|
| 2011 |
Zhao M, Sano D, Pickering CR, Jasser SA, Henderson YC, Clayman GL, Sturgis EM, Ow TJ, Lotan R, Carey TE, Sacks PG, Grandis JR, Sidransky D, Heldin NE, Myers JN. Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 7248-64. PMID 21868764 DOI: 10.1158/1078-0432.Ccr-11-0690 |
0.407 |
|
| 2011 |
Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, Zhang N, El-Naggar AK, Jasser SA, Weinstein JN, Treviño L, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (New York, N.Y.). 333: 1154-7. PMID 21798897 DOI: 10.1126/Science.1206923 |
0.46 |
|
| 2011 |
Sandulache VC, Ow TJ, Pickering CR, Frederick MJ, Zhou G, Fokt I, Davis-Malesevich M, Priebe W, Myers JN. Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells. Cancer. 117: 2926-38. PMID 21692052 DOI: 10.1002/Cncr.25868 |
0.438 |
|
| 2010 |
Fordyce C, Fessenden T, Pickering C, Jung J, Singla V, Berman H, Tlsty T. DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions. Cancer Prevention Research (Philadelphia, Pa.). 3: 190-201. PMID 20028875 DOI: 10.1158/1940-6207.Capr-09-0229 |
0.633 |
|
| 2010 |
William WN, Nunez M, Gu X, Jacobs RW, Litvak AM, Pickering CR, Lee J, El-Naggar AK, Glisson BS, Myers J. Prognostic value of biomarkers in tissue microarrays (TMAs) of squamous cell carcinomas of the oral tongue (SCCOT). Journal of Clinical Oncology. 28: 5548-5548. DOI: 10.1200/Jco.2010.28.15_Suppl.5548 |
0.359 |
|
| 2006 |
Zhang J, Pickering CR, Holst CR, Gauthier ML, Tlsty TD. p16INK4a modulates p53 in primary human mammary epithelial cells. Cancer Research. 66: 10325-31. PMID 17079452 DOI: 10.1158/0008-5472.Can-06-1594 |
0.702 |
|
| 2005 |
Gauthier ML, Pickering CR, Miller CJ, Fordyce CA, Chew KL, Berman HK, Tlsty TD. p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue. Cancer Research. 65: 1792-9. PMID 15753376 DOI: 10.1158/0008-5472.Can-04-3507 |
0.638 |
|
| 2001 |
Venkatachalam S, Tyner SD, Pickering CR, Boley S, Recio L, French JE, Donehower LA. Is p53 haploinsufficient for tumor suppression? Implications for the p53+/- mouse model in carcinogenicity testing Toxicologic Pathology. 29: 147-154. PMID 11695551 DOI: 10.1080/019262301753178555 |
0.399 |
|
| Show low-probability matches. |